Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production

Analytical and Bioanalytical Chemistry

Volumn 403, Issue 7, 2012, Pages 1841-1850

  Itoh, Yoshiharu ^a   Ezawa, Atsuko ^a   Kikuchi, Kaori ^a   Tsuruta, Yoshinari ^b   Niwa, Toshimitsu ^c  

^a KUREHA CORPORATION   (Japan)

^b Hemodialysis Center   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Endothelial cell; Hemodialysis; Indoxyl sulfate; Protein binding; Reactive oxygen species; Uremic toxin

Indexed keywords

HEMODIALYSIS; INDOXYL SULFATE; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; UREMIC TOXINS;

AMINO ACIDS; BIOCHEMISTRY; BODY FLUIDS; CHROMATOGRAPHY; DIALYSIS; ELECTROSPRAY IONIZATION; ENDOTHELIAL CELLS; HEMODIALYZERS; LIQUIDS; MASS SPECTROMETRY; METABOLITES; OXYGEN; PROTEINS; TOXIC MATERIALS;

SULFUR COMPOUNDS;

PROTEIN; REACTIVE OXYGEN METABOLITE; TOXIN;

AGED; BLOOD; CELL CULTURE; CONFERENCE PAPER; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY; TANDEM MASS SPECTROMETRY; UREMIA; VASCULAR ENDOTHELIUM;

AGED; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEINS; REACTIVE OXYGEN SPECIES; RENAL DIALYSIS; TANDEM MASS SPECTROMETRY; TOXINS, BIOLOGICAL; UREMIA;

EID: 84863775428     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-5929-3     Document Type: Conference Paper

References (26)

1. Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W, European Uremic Toxin Work Group (EUTox) (2003) Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934-1943
2. Yavuz A, Tetta C, Ersoy FF, D'intini V, Ratanarat R, De Cal M, Bonello M, Bordoni V, Salvatori G, Andrikos E, Yakupoglu G, Levin NW, Ronco C (2005) Uremic toxins: a new focus on an old subject. Semin Dial 18:203-211
3. Niwa T (2011) Update of uremic toxin research by mass spectrometry. Mass Spectrom Rev 30:510-521
4. Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Vanholder R, Brunet P (2009) Protein-bound toxins-update 2009. Semin Dial 22:334-339
5. Kikuchi K, Itoh Y, Tateoka R, Ezawa A, Murakami K, Niwa T (2010) Metabolomic analysis of uremic toxins by liquid chromatography/ electrospray ionization-tandem mass spectrometry. J Chromatogr B 878:1662-1668
6. Kikuchi K, Itoh Y, Tateoka R, Ezawa A, Murakami K, Niwa T (2010) Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry. J Chromatogr B 878:2997-3002
7. Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Brunet P (2011) Vascular incompetence in dialysis patients-protein-bound uremic toxins and endothelial dysfunction. Semin Dial 24:327-337
8. Annuk M, Zilmer M, Lind L, Linde T, Fellström B (2001) Oxidative stress and endothelial function in chronic renal failure. J Am Soc Nephrol 12:2747-2752
9. Dou L, Jourde-Chiche N, Faure V, Cerini C, Berland Y, Dignat-George F, Brunet P (2007) The uremic solute indoxyl sulphate induces oxidative stress in endothelial cells. J Thromb Haemost 5:1302-1308
10. Tumur Z, Niwa T (2009) Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells. Am J Nephrol 29:551-557
11. Tumur Z, Shimizu H, Enomoto A, Miyazaki H, Niwa T (2010) Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kB activation. Am J Nephrol 31:435-441
12. Nakai D, Kumamoto K, Sakikawa C, Kosaka T, Tokui T (2004) Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method. J Pharm Sci 93:847-854
13. Aronov PA, Luo FJ, Plummer NS, Quan Z, Holmes S, Hostetter TH, Meyer TW (2011) Colonic contribution to uremic solutes. J Am Soc Nephrol 22:1769-1776
14. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G (2009) Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 106:3698-3703
15. Niwa T, Ise M (1994) Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 124:96-104
16. Niwa T, Ise M, Miyazaki T (1994) Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Am J Nephrol 14:207-212
17. Miyazaki T, Ise M, Seo H, Niwa T (1997) Indoxyl sulfate increases the gene expressions of TGF-β1, TIMP-1 and pro-a1(I) collagen in uremic rat kidneys. Kidney Int 52(S62):S15-S22
18. Enomoto A, Takeda M, Tojo A, Sekine T, Cha SH, Khamdang S, Takayama F, Aoyama I, Nakamura S, Endou H, Niwa T (2002) Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol 13:1711-1720
19. Adijiang A, Goto S, Uramoto S, Nishijima F, Niwa T (2008) Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats. Nephrol Dial Transplant 23:1892-1901
20. Niwa T (2010) Indoxyl sulfate is a nephro-vascular toxin. J Ren Nutr 20(Suppl 1):S2-S6
21. Schepers E, Glorieux G, Vanholder R (2010) The gut: the forgotten organ in uremia? Blood Purif 29:130-136
22. Meijers BK, De Loor H, Bammens B, Verbeke K, Vanrenterghem Y, Evenepoel P (2009) p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol 4:1932-1938
23. Meijers B, Toussaint ND, Meyer T, Bammens B, Verbeke K, Vanrenterghem Y, Kerr PG, Evenepoel P (2011) Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis. Am J Nephrol 34:226-232
24. Jankowski J, van der Giet M, Jankowski V, Schmidt S, Hemeier M, Mahn B, Giebing G, Tolle M, Luftmann H, Schluter H, Zidek W, Tepel M (2003) Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest 112:256-264
25. Meyer TW, Peattie JW, Miller JD, Dinh DC, Recht NS, Walther JL, Hostetter TH (2007) Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol 18:868-874
26. Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsukushi S, Tsutsui S (1997) The protein metabolite hypothesis, a model for the progression of renal failure: an oral sorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int 52(Suppl 62):S23-S28